about
Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responsesTracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study.Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements.Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis.Crimean-Congo hemorrhagic fever virus activates endothelial cells.Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro.Host-directed therapies for tuberculous pericarditis.Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation.Viability and proliferation of rat MSCs on adhesion protein-modified PET and PU scaffolds.Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1/c-FOS-mediated induction of interleukin 6 expression.Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation.Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy?Bone repair using periodontal ligament progenitor cell-seeded constructs.Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression.Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua.Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?Editorial comment: variables affecting the presence of mesenchymal stromal cells in the peripheral blood and their relationship with apheresis productControl of neutrophil influx during peritonitis by transcriptional cross-regulation of chemokine CXCL1 by IL-17 and IFN-γIntravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical GuidelinesMulti-Parameter Analysis of Biobanked Human Bone Marrow Stromal Cells Shows Little Influence for Donor Age and Mild Comorbidities on Phenotypic and Functional PropertiesPreclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal CellsMesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
P50
Q33958064-3C546CCE-D891-4ECB-9F87-083154916D1CQ34236181-85752A82-720F-45F0-A8A6-63A56301905EQ34619694-BB73EEBC-BA8C-492D-911F-C5E3D3C53BC2Q35240062-E0D45210-BB04-424F-B72D-64189D602544Q37472831-D0601E22-3942-4E7E-B862-492CDED9DC2EQ37945318-DD7C1419-9895-48C7-92FA-5021D092B1D6Q40119705-9AF19B42-879E-47FE-B5EC-66E157AA1B5CQ40322916-52A0DC3F-442A-46C9-8398-BF926680C80CQ40614326-F6D908D0-512F-475D-9AFC-D0F3A39D14E9Q41383764-63510DC9-68C3-4CB5-AE9E-0BCADE11271AQ43678493-55609953-E5A5-409F-AAE4-EBB9E5C2DD04Q44805432-5F81DF6F-D8DD-4669-9CD7-72BB29579C59Q47307137-E61F67C0-FF85-4517-A0A7-751F89343903Q50163129-541DB367-C278-4614-A762-318F64552099Q50224283-FE83D3AD-D619-4337-BA5E-843A0C2E8104Q50244858-481025EF-C0A0-497B-816F-582742F81732Q52658261-A6D13C9E-7B90-43A3-8E6A-56A674ED5C60Q52855660-E4893082-0029-4DC6-9A27-A777587AF8C1Q52864189-B32BC8FE-9F0A-4465-B0D8-A88BBC991307Q53171235-B6D1A731-91B2-41DB-AA7C-809D82B3FFB9Q61043358-3B4980F4-A955-4F7D-9F5A-388A593A2B44Q89616815-8CA0BB4A-D421-43A2-98E1-A6D66A095048Q90787054-D3BE9028-EE48-4310-A2B1-92FC148B8666Q91317101-672DF7C1-D235-4EFD-AFEA-E2CD60628CF9Q91528747-F77F3834-8D2B-482F-885C-35F626F2DC09Q91708011-630C2B14-6F2C-47C9-887F-13A9B80074C8Q92650424-9160D51B-6B60-4322-92B6-7EC1544E1BA4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Guido Moll
@ast
Guido Moll
@en
Guido Moll
@es
Guido Moll
@sl
type
label
Guido Moll
@ast
Guido Moll
@en
Guido Moll
@es
Guido Moll
@sl
prefLabel
Guido Moll
@ast
Guido Moll
@en
Guido Moll
@es
Guido Moll
@sl
P1053
Q-1044-2018
P106
P108
P1960
BG2rovgAAAAJ
P2038
Guido_Moll
P21
P2798
P31
P3829
P4012
P496
0000-0001-6173-5957